TGA2.2 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to TG2 Antibodies

Transglutaminase 2 (TG2) is a multifunctional enzyme with roles in protein crosslinking, extracellular matrix stabilization, and immune response modulation . Antibodies against TG2 are critical in diagnostic and therapeutic contexts, particularly in autoimmune and fibrotic diseases.

Role of Anti-TG2 Antibodies in Celiac Disease

  • Pathogenic Mechanism: Anti-TG2 antibodies are produced locally in the small intestine during gluten exposure. These IgA/IgG antibodies target TG2-gliadin complexes, forming deposits in the intestinal mucosa before appearing in circulation .

  • Gluten Dependence: Antibody production requires HLA-DQ2/DQ8-restricted gliadin-specific T cells, which provide activation signals to TG2-specific B cells .

  • Diagnostic Utility: Serum anti-TG2 antibodies are hallmark biomarkers for celiac disease, with >90% sensitivity and specificity .

Key Data:

ParameterFindingsSource
Antibody OriginIntestinal plasma cells (VH5 gene bias)
Serum vs. Mucosal LevelsMucosal deposits precede serum detection
Diet ResponseAntibody levels decline on gluten-free diets

Therapeutic Antibody Development Against TG2

Recent efforts focus on inhibiting extracellular TG2 to combat fibrosis:

  • High-Affinity Antibodies: AB1, DC1, and BB7 antibodies inhibit human TG2 transamidation activity (IC<sub>50</sub> ≈6–7 nM) by targeting the catalytic core (amino acids 313–327) .

  • Species Specificity: Most antibodies show weak inhibition of rat TG2, limiting preclinical models .

  • Functional Impact: These antibodies reduce extracellular matrix (ECM) accumulation in human renal fibrosis models .

Therapeutic Antibody Comparison:

AntibodyTarget EpitopeIC<sub>50</sub> (nM)Species Reactivity
AB1TG2 core (313–327)6.2Human-specific
DC1TG2 core (313–327)6.9Human-specific
BB7TG2 core (313–327)7.1Human-specific
Data sourced from

Antibody Specificity and Detection Methods

Commercial antibodies like AF4376 and ab109200 are validated for TG2 detection:

  • AF4376:

    • Detects TG2 in humans, mice, and rats via Western blot (75 kDa band) .

    • Validated in knockout cell lines (A549 TG2-KO) .

  • ab109200:

    • Rabbit monoclonal antibody (clone EP2957) with specificity confirmed in HeLa and A549 TG2-KO cells .

    • Cross-reactivity observed with non-TG2 bands in Western blots .

Validation Table:

Assay TypeAF4376 Performanceab109200 Performance
Western BlotSpecific band in WT, absent in KOSpecific band in WT, absent in KO
ImmunocytochemistryStrong signal in WT cellsSignal loss in KO cells
Species ReactivityHuman, mouse, ratHuman
Data from

Clinical Implications Beyond Celiac Disease

  • Cancer Prognosis:

    • Intracellular TG2: Associated with better prognosis in hormone receptor-negative breast cancer (HR=0.56) .

    • Extracellular TG2: Linked to poorer outcomes in hormone receptor-positive cases (HR=1.60) .

  • Fibrosis: TG2 inhibitors like AB1/DC1/BB7 show promise in reducing ECM deposition .

Research Limitations and Future Directions

  • Unresolved Questions: The pathogenic role of mucosal anti-TG2 antibodies in celiac disease remains unclear .

  • Therapeutic Challenges: Species specificity and intracellular TG2 functions complicate drug development .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
TGA2.2 antibody; Os03g0318600 antibody; LOC_Os03g20310 antibody; OsJ_10635 antibody; Transcription factor TGA2.2 antibody; OsNIF1 antibody; OsbZIP1 antibody; bZIP transcription factor 28 antibody; OsbZIP28 antibody
Target Names
TGA2.2
Uniprot No.

Target Background

Function
Transcriptional regulator involved in defense response.
Database Links
Protein Families
BZIP family
Subcellular Location
Nucleus.

Q&A

What is TGA2.2 and why is it important in plant research?

TGA2.2 is a tobacco bZIP transcription factor that belongs to the TGA family of proteins. It has distinct roles in plant defense responses and development . As a transcription factor, TGA2.2 binds to specific DNA sequences, primarily the TGACG pentamer, which serves as the common TGA dimer binding site . TGA2.2 interacts with the promoter of the salicylic acid-inducible PR-1a gene in Nicotiana tabacum, highlighting its importance in plant defense signaling pathways .

How does TGA2.2 differ from other TGA family members?

TGA2.2 is a clade II member of the TGA family, which typically exhibits shorter N-termini (approximately 40-50 amino acids) compared to other TGA clades. While most TGA family members can recognize the TGACG pentamer binding site, TGA2.2 has distinct roles in plant defense and development compared to its close relative TGA2.1 . The N-terminus of clade II members, including TGA2.2, shows high disorder probability spanning its entire length, which may contribute to its functional specificity .

What are the standard methods for validating a TGA2.2 antibody?

Similar to validation protocols used for other antibodies, researchers should:

  • Test the antibody in Western blot assays using wild-type and TGA2.2 knockout cell lines

  • Perform immunocytochemistry with appropriate controls including knockout cells

  • Use immunoprecipitation followed by detection with another antibody

  • Include negative controls (IgG) in all experiments

The knockout validation approach, as demonstrated with the Transglutaminase 2 antibody, provides the most compelling evidence of specificity .

How can I use a TGA2.2 antibody for Western blot analysis?

For optimal Western blot results with TGA2.2 antibodies:

  • Use PVDF membrane for protein transfer

  • Apply approximately 0.5 μg/mL antibody concentration (based on similar antibody protocols)

  • Follow with appropriate HRP-conjugated secondary antibody

  • Conduct the experiment under reducing conditions

  • Include proper controls such as knockout cell lines to confirm specificity

TGA2.2 should appear as a band at its expected molecular weight (varies by species but typically 40-45 kDa for TGA proteins).

What is the optimal protocol for chromatin immunoprecipitation (ChIP) with TGA2.2 antibodies?

For ChIP assays targeting TGA2.2:

  • Use approximately 3g of fresh leaf tissue per sample

  • Apply 5 μL of antibody for immunoprecipitation

  • Include purified IgG as a nonspecific antibody control

  • Quantify DNA in samples via qPCR

  • Design primers to amplify promoter regions containing TGA elements

  • Focus on regions with the TGACG pentamer or TGACGTCA palindrome, as these are the primary binding sites for TGA transcription factors

How should I design an immunoprecipitation protocol for TGA2.2?

Based on protocols for similar applications:

  • Prepare cell/tissue lysates under conditions that maintain protein complexes

  • Use 2.0 μg of antibody pre-coupled to Dynabeads protein G

  • Include controls: starting material (4%), unbound fraction (4%), and immunoprecipitate

  • Detect immunoprecipitated TGA2.2 with a second antibody from a different species

  • Include a Ponceau stain of the blot transfer to verify protein loading

This approach will help identify TGA2.2 interaction partners and verify antibody specificity.

How can I study TGA2.2's role in salicylic acid-mediated defense responses?

To investigate TGA2.2's function in salicylic acid (SA) signaling:

  • Perform ChIP assays targeting the PR-1a gene promoter, which contains binding sites for TGA2.2 at the as-1-like element (position -592)

  • Compare TGA2.2 binding before and after SA treatment

  • Study co-recruitment of interacting partners like NtWRKY12

  • Analyze the effect of TGA2.2 knockout/knockdown on SA-inducible gene expression

  • Conduct transactivation experiments in protoplasts to test TGA2.2's ability to activate reporter genes with TGA binding elements

What experimental approaches can reveal TGA2.2's protein interaction network?

To map TGA2.2 protein interactions:

  • Perform co-immunoprecipitation with TGA2.2 antibodies followed by mass spectrometry

  • Use yeast two-hybrid assays with TGA2.2 as bait

  • Conduct bimolecular fluorescence complementation (BiFC) to visualize interactions in planta

  • Consider proximity-dependent biotin identification (BioID) to capture transient interactions

Based on known TGA interactions, look specifically for interactions with WRKY transcription factors, NPR proteins, CYCLIN-DEPENDENT KINASE 8, and ROXY glutaredoxins .

How do structural characteristics of TGA2.2 affect antibody development and performance?

Structural FeatureImplications for Antibody DevelopmentRecommendation
bZIP domainHighly conserved across TGA familyAvoid targeting for specific detection
N-terminal regionShort (40-50aa) and highly disorderedChallenging target but offers specificity
C-terminal regionMore structuredBetter for antibody stability but less specific
Dimerization domainsMay be inaccessible in complexesTarget epitopes that remain accessible

The intrinsic disorder patterns of TGA N-terminal regions appear to be clade-dependent, with clade II members (including TGA2.2) exhibiting high disorder probability throughout their short N-termini .

How can I distinguish between TGA2.2 homodimers and heterodimers in my research?

TGA transcription factors can form homodimers, heterodimers, and higher-order complexes . To differentiate between these forms:

  • Use sequential ChIP (Re-ChIP) with antibodies against different TGA family members

  • Perform size exclusion chromatography followed by Western blotting

  • Apply native gel electrophoresis to preserve protein complexes

  • Consider chemical crosslinking to stabilize complexes before analysis

  • Use techniques like FRET-FLIM to study interactions in living cells

The oligomerization properties of TGA2 depend on the region spanning its N-terminus and bZIP domain .

What factors affect TGA2.2 DNA binding that should be considered in ChIP experiments?

Several factors influence TGA2.2 DNA binding that are important for ChIP experimental design:

  • The TGACG pentamer is the minimal binding site, but the TGACGTCA palindrome provides stronger binding

  • Ca²⁺/calmodulin interactions can enhance TGA binding to DNA elements

  • Post-translational modifications may affect DNA binding affinity

  • Interaction with cofactors like ROXY glutaredoxins modulates binding

  • The local DNA structure beyond sequence can affect binding specificity

When designing ChIP-qPCR primers, consider these factors and target regions with known or predicted TGA binding sites.

How do post-translational modifications affect TGA2.2 function and antibody recognition?

TGA transcription factors undergo various post-translational modifications that can affect both their function and antibody recognition:

  • Phosphorylation may alter protein conformation and DNA-binding activity

  • Nitrosylation can modify TGA activity in response to stress

  • SUMOylation may affect nuclear localization and protein stability

  • Redox modifications through glutaredoxin interactions influence activity

When developing or using TGA2.2 antibodies, consider whether your antibody target region contains modification sites, as these may mask epitopes under certain conditions .

What experimental approaches can determine how calcium signaling affects TGA2.2 activity?

To study calcium regulation of TGA2.2:

  • Perform DNA binding assays with and without Ca²⁺/calmodulin

  • Use calmodulin-binding domain mutants to assess functional significance

  • Conduct calcium ionophore treatments before ChIP or immunoprecipitation

  • Test for direct interaction between TGA2.2 and calmodulin using pull-down assays

Several TGAs have been identified as calmodulin (CaM) interactors, and the CaM/Ca²⁺ complex enhances TGA3 binding to TGACG elements both in vivo and in vitro .

How conserved is TGA2.2 across plant species, and what implications does this have for antibody cross-reactivity?

Plant SpeciesTGA2.2 HomologsSequence IdentityPredicted Cross-reactivity
Tobacco (N. tabacum)TGA2.2, TGA2.1100%, ~85%High, Moderate
ArabidopsisAtTGA2, AtTGA5, AtTGA6~60-70%Low-Moderate
Other SolanaceaeVarious TGA2-like~70-90%Moderate
MonocotsTGA-like~40-50%Very low

Antibodies raised against specific epitopes should be tested for cross-reactivity with related TGA proteins, especially when working with different plant species .

How can I design experiments to study TGA2.2 function in species lacking genetic tools?

For studying TGA2.2 in non-model plants:

  • Use antibodies validated in model systems to identify and characterize homologs

  • Apply virus-induced gene silencing (VIGS) to knock down TGA2.2 expression

  • Develop transient expression systems using Agrobacterium infiltration

  • Implement heterologous expression in yeast or Arabidopsis to test functionality

  • Use CRISPR/Cas systems adapted for plant species without established transformation protocols

Cross-species complementation experiments can help determine functional conservation of TGA2.2 across different plant lineages.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.